Trial Profile
A randomised controlled trial of Ivabradine and Atorvastatin in emergent orthopaedic lower limb surgery for neck of femur fracture in elderly patients: a mechanistic study of peri-operative myocardial injury and its prevention using computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Ivabradine (Primary)
- Indications Myocardial ischaemia
- Focus Biomarker; Therapeutic Use
- 07 Sep 2014 Status changed from not yet recruiting to recruiting according to Trial design published in the Trials.
- 12 Apr 2012 New trial record